Company news
Proteomics International Laboratories Ltd. (ASX:PIQ) news
Proteomics International Laboratories Ltd. news releases on 6ix. Latest, Jun 13, 2017: Clinical validation study confirms PromarkerD performance
Press releases — page 5
Clinical validation study confirms PromarkerD performance
June 12, 2017
World leading laboratory launches clinical trials testing
May 8, 2017
Appendix 4C - March 2017 Quarterly Report
April 26, 2017
PromarkerD Update
April 3, 2017
Frost & Sullivan- PromarkerD diagnostic test world leading
March 26, 2017
Proteomics targets diabetic kidney disease in Asia
March 20, 2017
Diabetic Kidney Disease Diagnostic Test Data Published
February 7, 2017
Appendix 4C - December 2016 Quarterly Report
January 24, 2017
Diabetic Kidney Disease patent granted in Russia
December 18, 2016
PromarkerD shows improved predictive ability and robustness
December 14, 2016
Proteomics completes $1.44 million Placement and offers SPP
December 1, 2016
Proteomics and Linear partner in testing and clinical trials
November 14, 2016
PromarkerD test kit production deal signed
November 10, 2016
Appendix 4C - September 2016 Quarterly Report
October 24, 2016
Proteomics targets gastro-causing parasite
October 19, 2016
Proteomics International receives FY16 R&D Tax Incentive
September 21, 2016
Proteomics investigates biomarkers for mesothelioma
September 6, 2016
Proteomics expands diagnostics portfolio to endometriosis
August 24, 2016
Proteomics first commercialisation deal for PromarkerD
August 17, 2016
Appendix 4C - June 2016 Quarterly Report
July 28, 2016
PromarkerD Development Advances in China
June 21, 2016